| Literature DB >> 16039518 |
Abstract
A study of a well-designed androgen-mustard conjugate provides evidence supporting a novel mechanism for its selective toxicity in androgen-receptor-positive cancer cells. This represents a solid step forward on the path toward effective hybrid toxins for targeted cancer therapy.Entities:
Mesh：
Substances：
Year: 2005 PMID： 16039518 DOI： 10.1016/j.chembiol.2005.07.002
Source DB: PubMed Journal: Chem Biol ISSN： 1074-5521